Delivery Order SPE2DB22D1002-SPE2DB25FLBD0

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,695.66, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. This is a firm fixed-price delivery order contract with an ultimate completion date of April 10, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,035.16, is for the delivery of the pharmaceutical product Aimovig 140 mg/ml autoinjector. It is a firm fixed-price delivery order contract with an ultimate completion date of April 9, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Aimovig 140 mg/ml autoinjector, with a ceiling value of $7,699.89 and a period of performance ending on April 18, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Aimovig 140 mg/ml autoinjector medication. The contract, valued at $5,619.12, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of December 20, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation noted for this award. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,256.01, is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a prescription medication. This is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,727.50, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement, and the ultimate completion date is February 7, 2025. The contract does not have a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,813.97, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical supply. The contract has an ultimate completion date of July 16, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,441.30 firm fixed-price delivery order contract is for the supply of the medication Aimovig 140 mg/ml autoinjector. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Aimovig 140 mg/ml autoinjector. The fixed-price contract has a ceiling value of $3,168.34 and a period of performance through July 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this order as part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,281.64, is for the delivery of the prescription medication Aimovig 140 mg/mL autoinjector. The award has an ultimate completion date of April 23, 2025 and is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FLBD0
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,934.01, is for the delivery of the medication Aimovig 140 mg/mL autoinjector. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement, and the performance period extends through April 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026.

Generated 7/21/25, 7:40 PM